These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22735606)

  • 1. The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
    Simental-Mendía LE; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1173-7. PubMed ID: 22735606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease in asymptomatic obese women.
    Rodriguez-Hernandez H; Cervantes-Huerta M; Gonzalez JL; Marquez-Ramirez MD; Rodriguez-Moran M; Guerrero-Romero F
    Ann Hepatol; 2010; 9(2):144-9. PubMed ID: 20526006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children.
    Koot BG; van der Baan-Slootweg OH; Bohte AE; Nederveen AJ; van Werven JR; Tamminga-Smeulders CL; Merkus MP; Schaap FG; Jansen PL; Stoker J; Benninga MA
    Obesity (Silver Spring); 2013 Mar; 21(3):583-90. PubMed ID: 23592667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
    Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease.
    Razavizade M; Jamali R; Arj A; Talari H
    Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):513-20. PubMed ID: 23060397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
    Ybarra J; Fernández S; Sánchez-Hernández J; Romeo JH; Ballesta-Lopez C; Guell J; Mearin F
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):654-60. PubMed ID: 24667349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children.
    El-Koofy N; El-Karaksy H; El-Akel W; Helmy H; Anwar G; El-Sayed R; El-Hennawy A
    Eur J Radiol; 2012 Nov; 81(11):3120-3. PubMed ID: 22817846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
    Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.
    Martin-Rodriguez JL; Gonzalez-Cantero J; Gonzalez-Cantero A; Arrebola JP; Gonzalez-Calvin JL
    Medicine (Baltimore); 2017 Apr; 96(17):e6770. PubMed ID: 28445310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters.
    Chunming L; Jianhui S; Hongguang Z; Chunwu Q; Xiaoyun H; Lijun Y; Xuejun Y
    Turk J Gastroenterol; 2015 Sep; 26(5):408-16. PubMed ID: 26215061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
    Huang SC; Yang YJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
    McPherson S; Anstee QM; Henderson E; Day CP; Burt AD
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):652-8. PubMed ID: 23325287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S; Jensen D; Hart J; Mohanty SR
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
    Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O
    Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
    Kim KS; Oh HJ; Kim DJ; Kim SK; Park SW; Cho YW; Huh KB
    Endocr J; 2013; 60(12):1295-301. PubMed ID: 24047563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.